Titre :
  • Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
Auteur : Bousser, MG ; Amarenco, P ; Chamorro, A ; Fisher, Martin ; Ford, Ian ; Fox, K. ; Hennerici, MG ; Mattle, HP ; Rothwell, PM ; PERFORM Study Investigators ; Pandolfo, Massimo
Informations sur la publication : Cerebrovascular diseases, 27, 5, (page 509-518)
Statut de publication : Publié, 2009
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Aged
Aged, 80 and over
Aspirin -- adverse effects
Aspirin -- therapeutic use
Cardiovascular Diseases -- etiology
Cardiovascular Diseases -- prevention & control
Dose-Response Relationship, Drug
Double-Blind Method
Endpoint Determination
Female
Humans
International Cooperation
Ischemic Attack, Transient -- complications
Ischemic Attack, Transient -- drug therapy
Male
Middle Aged
Naphthalenes -- adverse effects
Naphthalenes -- therapeutic use
Platelet Aggregation Inhibitors -- adverse effects
Platelet Aggregation Inhibitors -- therapeutic use
Propionic Acids -- adverse effects
Propionic Acids -- therapeutic use
Receptors, Thromboxane -- antagonists & inhibitors
Stroke -- complications
Stroke -- drug therapy
Stroke -- etiology
Stroke -- prevention & control
Treatment Outcome
Note : Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1015-9770 
info:doi/10.1159/000212671
info:pii/000212671
info:pmid/19372653